Paul D. Blanc

Prof. Paul D. Blanc


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
PBPaul D. Blanc
Paul D. Blanc
IAIsabella Annesi-Maesano
Isabella Annesi-Maesano
John BalmesJohn Balmes
John Balmes
KCKristin J. Cummings
Kristin J. Cummings
DFDavid Fishwick
David Fishwick
CRCarrie A Redlich
Carrie A Redlich
Rationale: Workplace inhalational hazards remain common worldwide, even though they are ameliorable. Previous American Thoracic Society documents have assessed the contribution of workplace exposures to asthma and chronic obstructive pulmonary disease on a population level, but not to other chronic respiratory diseases. The goal of this document is to report an in-depth literature review and data synthesis of the occupational contribution to the burden of the major nonmalignant respiratory diseases, including airway diseases; interstitial fibrosis; hypersensitivity pneumonitis; other noninfectious granulomatous lung diseases, including sarcoidosis; and selected respiratory infections. Methods: Relevant literature was identified for each respiratory condition. The occupational population attributable fraction (PAF) was estimated for those conditions for which there were sufficient population-based studies to allow pooled estimates. For the other conditions, the occupational burden of disease was estimated on the basis of attribution in case series, incidence rate ratios, or attributable fraction within an exposed group. Results: Workplace exposures contribute substantially to the burden of multiple chronic respiratory diseases, including asthma (PAF, 16%); chronic obstructive pulmonary disease (PAF, 14%); chronic bronchitis (PAF, 13%); idiopathic pulmonary fibrosis (PAF, 26%); hypersensitivity pneumonitis (occupational burden, 19%); other granulomatous diseases, including sarcoidosis (occupational burden, 30%); pulmonary alveolar proteinosis (occupational burden, 29%); tuberculosis (occupational burden, 2.3% in silica-exposed workers and 1% in healthcare workers); and community-acquired pneumonia in working-age adults (PAF, 10%). Conclusions: Workplace exposures contribute to the burden of disease across a range of nonmalignant lung conditions in adults (in addition to the 100% burden for the classic occupational pneumoconioses). This burden has important clinical, research, and policy implications. There is a pressing need to improve clinical recognition and public health awareness of the contribution of occupational factors across a range of nonmalignant respiratory diseases.

29 January 2009 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
KTKjell Torén
Kjell Torén
PBPaul D. Blanc
Paul D. Blanc
The aim of this paper is to highlight emerging data on occupational attributable risk in asthma. Despite well documented outbreaks of disease and the recognition of numerous specific causal agents, occupational exposures previously had been relegated a fairly minor role relative to other causes of adult onset asthma. In recent years there has been a growing recognition of the potential importance of asthma induced by work-related exposures

1 May 2012 in Sleep Medicine
Verified
Journal Article
Closed access
TOTheodore A. Omachi
Theodore A. Omachi
PBPaul D. Blanc
Paul D. Blanc
DCDavid M. Claman
David M. Claman
HCHubert Chen
Hubert Chen
EYEdward H. Yelin
Edward H. Yelin
PKPatti Katz
Patti Katz

14 August 2012 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
TOTheodore A. Omachi
Theodore A. Omachi
USUrmimala Sarkar
Urmimala Sarkar
EYEdward H. Yelin
Edward H. Yelin
PBPaul D. Blanc
Paul D. Blanc
PKPatti Katz
Patti Katz

29 January 2007 in Respiratory Research
Verified
Journal Article
Open access
MEMark D Eisner
Mark D Eisner
PBPaul D. Blanc
Paul D. Blanc
SSStephen Sidney
Stephen Sidney
EYEdward H Yelin
Edward H Yelin
PLPhenius V Lathon
Phenius V Lathon
CICarlos Iribarren
Carlos Iribarren
Low body mass index has been associated with increased mortality in severe COPD. The impact of body composition earlier in the disease remains unclear. We studied the impact of body composition on the risk of functional limitation in COPD. We used bioelectrical impedance to estimate body composition in a cohort of 355 younger adults with COPD who had a broad spectrum of severity. Among women, a higher lean-to-fat ratio was associated with a lower risk of self-reported functional limitation after controlling for age, height, pulmonary function impairment, race, education, and smoking history (OR 0.45 per 0.50 increment in lean-to-fat ratio; 95% CI 0.28 to 0.74). Among men, a higher lean-to-fat ratio was associated with a greater distance walked in 6 minutes (mean difference 40 meters per 0.50 ratio increment; 95% CI 9 to 71 meters). In women, the lean-to-fat ratio was associated with an even greater distance walked (mean difference 162 meters per 0.50 increment; 95% CI 97 to 228 meters). In women, higher lean-to-fat ratio was also associated with better Short Physical Performance Battery Scores. In further analysis, the accumulation of greater fat mass, and not the loss of lean mass, was most strongly associated with functional limitation among both sexes. Body composition is an important non-pulmonary impairment that modulates the risk of functional limitation in COPD, even after taking pulmonary function into account. Body composition abnormalities may represent an important area for screening and preventive intervention in COPD.

1 August 2009 in The American Journal of Medicine
Verified
Journal Article
Closed access
TOTheodore A. Omachi
Theodore A. Omachi
PKPatti Katz
Patti Katz
EYEdward H. Yelin
Edward H. Yelin
SGSteven E. Gregorich
Steven E. Gregorich
CICarlos Iribarren
Carlos Iribarren
MEMark D. Eisner
Mark D. Eisner